{"id":"NCT01104792","sponsor":"Forest Laboratories","briefTitle":"Long-term Study of Cariprazine in Patients With Schizophrenia","officialTitle":"Evaluation of the Long-term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients With Schizophrenia","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-05-31","primaryCompletion":"2013-01-31","completion":"2013-01-31","firstPosted":"2010-04-15","resultsPosted":"2019-07-26","lastUpdate":"2019-07-26"},"enrollment":752,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Schizophrenia"],"interventions":[{"type":"DRUG","name":"Cariprazine","otherNames":["RGH-188"]}],"arms":[{"label":"Cariprazine","type":"EXPERIMENTAL"}],"summary":"The objective of this study is to evaluate the long-term safety, tolerability, and pharmacokinetics of cariprazine in patients with schizophrenia.","primaryOutcome":{"measure":"Change From Baseline to Week 48 in the PANSS Total Score","timeFrame":"Baseline to Week 48","effectByArm":[{"arm":"Cariprazine","deltaMin":66.5,"sd":12.1}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":1},"locations":{"siteCount":86,"countries":["United States","Colombia","India","Romania","Russia","Ukraine"]},"refs":{"pmids":["34091867","33854317","28836957"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":59,"n":586},"commonTop":["Akathisia","Headache","Insomnia","Weight increased","Anxiety"]}}